Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA PRFZ

Index	RUT	P/E	-	EPS (ttm)	-1.83	Insider Own	10.17%	Shs Outstand	301.96M	Perf Week	6.60%
Market Cap	463.57M	Forward P/E	-	EPS next Y	-0.46	Insider Trans	-2.59%	Shs Float	271.28M	Perf Month	15.41%
Enterprise Value	886.46M	PEG	-	EPS next Q	-0.14	Inst Own	57.81%	Short Float	16.82%	Perf Quarter	-23.63%
Income	-546.38M	P/S	2.90	EPS this Y	71.61%	Inst Trans	5.81%	Short Ratio	6.88	Perf Half Y	8.10%
Sales	160.00M	P/B	86.67	EPS next Y	11.61%	ROA	-53.45%	Short Interest	45.63M	Perf YTD	-17.91%
Book/sh	0.02	P/C	1.66	EPS next 5Y	38.83%	ROE	-213.45%	52W High	2.73 -43.77%	Perf Year	16.29%
Cash/sh	0.93	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-77.25%	52W Low	0.85 80.35%	Perf 3Y	-86.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	-196.47%	Volatility	8.66% 6.91%	Perf 5Y	-95.28%
Dividend TTM	-	EV/Sales	5.54	EPS Y/Y TTM	-61.50%	Oper. Margin	-330.95%	ATR (14)	0.11	Perf 10Y	-82.44%
Dividend Ex-Date	-	Quick Ratio	4.47	Sales Y/Y TTM	3.89%	Profit Margin	-341.47%	RSI (14)	56.80	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	5.15	EPS Q/Q	71.82%	SMA20	11.66%	Beta	2.41	Target Price	2.29
Payout	-	Debt/Eq	131.29	Sales Q/Q	13.82%	SMA50	0.17%	Rel Volume	1.31	Prev Close	1.45
Employees	485	LT Debt/Eq	131.21	Earnings	Feb 12 AMC	SMA200	-8.08%	Avg Volume	6.63M	Price	1.53
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.53% 3.74%	Trades		Volume	1,305,608	Change	5.86%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20

Show Previous Ratings

Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	Loading…
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
11:01PM	Loading…
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
06:15PM	Loading…
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)
Sep-15-25 11:46AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Sep-14-25 11:36PM	Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest (StockStory)
Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM

Open in Screener

DNA

Ginkgo Bioworks Holdings Inc

Apr 14 • 10:11AM ET

7.04

+0.36 5.39 %

Healthcare • Biotechnology • USA • NYSE

DNA Ginkgo Bioworks Holdings Inc daily Stock Chart

Peers: REGN SGMO EDIT CRSP NTLA TWST DNLI BEAM FATE CERS

| Held by: VTI IWM VXF KOMP IWN THNQ IBB SCHA PRFZ VTWO

Index	RUT	P/E	-	EPS (ttm)	-5.68	Insider Own	24.90%	Shs Outstand	46.79M	Perf Week	3.23%
Market Cap	431.96M	Forward P/E	-	EPS next Y	-3.86	Insider Trans	-3.25%	Shs Float	43.82M	Perf Month	3.53%
Enterprise Value	442.19M	PEG	-	EPS next Q	-1.21	Inst Own	58.27%	Short Float	14.03%	Perf Quarter	-26.36%
Income	-312.76M	P/S	2.54	EPS this Y	21.53%	Inst Trans	5.52%	Short Ratio	5.35	Perf Half Y	-47.93%
Sales	170.16M	P/B	0.76	EPS next Y	12.78%	ROA	-25.05%	Short Interest	6.15M	Perf YTD	-15.28%
Book/sh	9.21	P/C	1.01	EPS next 5Y	-	ROE	-51.08%	52W High	17.58 -59.95%	Perf Year	-15.79%
Cash/sh	7.00	P/FCF	-	EPS past 3/5Y	51.73% -7.49%	ROIC	-33.79%	52W Low	5.37 31.10%	Perf 3Y	-86.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-29.11% 17.29%	Gross Margin	40.49%	Volatility	7.74% 8.04%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.60	EPS Y/Y TTM	46.46%	Oper. Margin	-184.60%	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.92	Sales Y/Y TTM	-25.06%	Profit Margin	-183.81%	RSI (14)	51.62	Recom	3.67
Dividend Gr. 3/5Y	- -	Current Ratio	4.92	EPS Q/Q	27.13%	SMA20	5.65%	Beta	1.59	Target Price	8.50
Payout	-	Debt/Eq	0.86	Sales Q/Q	-23.84%	SMA50	-7.04%	Rel Volume	0.83	Prev Close	6.68
Employees	485	LT Debt/Eq	0.82	Earnings	Feb 26 AMC	SMA200	-31.11%	Avg Volume	1.15M	Price	7.04
IPO	Apr 19, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.09% -11.03%	Trades		Volume	142,439	Change	5.39%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform	$3.50 → $2.50
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell	$3 → $1.25
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy	$6
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight	$5
May-18-22	Downgrade	BofA Securities	Neutral → Underperform	$3
Mar-02-22	Resumed	Cowen	Outperform	$12
Feb-23-22	Initiated	Goldman	Neutral	$7
Feb-01-22	Initiated	BofA Securities	Neutral	$6
Jan-28-22	Initiated	BofA Securities	Buy	$8
Jan-07-22	Initiated	BTIG Research	Buy	$12
Nov-29-21	Initiated	Jefferies	Buy	$16
Oct-13-21	Initiated	Raymond James	Outperform	$14.50
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy	$14

Show Previous Ratings

Mar-07-26 03:01PM	Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen (Benzinga)
Mar-02-26 08:00AM	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure (PR Newswire)
Feb-28-26 12:07AM	Ginkgo Bioworks Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 08:02PM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -30.48%
11:50AM	Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter (Benzinga)
08:30AM	Loading…
08:30AM	Ginkgo Bioworks Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
Feb-26-26 04:26PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business (PR Newswire)
Feb-25-26 07:35AM	Ginkgo Bioworks Holdings Inc (DNA) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.87%
Feb-19-26 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation (PR Newswire) +8.27%
Feb-18-26 08:00AM	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products (PR Newswire)
Feb-17-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Feb-10-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks) -9.06%
Feb-06-26 06:26AM	Ginkgo, OpenAI Cut Protein Costs by 40% (GuruFocus.com) +21.39%
Feb-05-26 02:00PM	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark (PR Newswire)
Feb-04-26 06:15PM	Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today (Zacks) -5.92%
06:15PM	Loading…
Jan-29-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors (Zacks)
Jan-23-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -6.36%
Jan-14-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-13-26 08:00AM	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-08-26 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks) -5.72%
Dec-31-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts (Zacks)
Dec-22-25 01:21PM	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach (PR Newswire) +8.52%
Dec-17-25 08:00AM	Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment (PR Newswire)
Dec-09-25 08:00AM	Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety (PR Newswire)
Dec-05-25 08:33AM	Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High-Throughput Phenotyping Platform for DOE's M2PC (PR Newswire)
Dec-03-25 08:00AM	STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy (PR Newswire)
Nov-18-25 08:00AM	Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health (PR Newswire)
Nov-07-25 04:00AM	Ginkgo Bioworks Holdings Inc (DNA) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... (GuruFocus.com) -20.80%
Nov-06-25 04:05PM	Ginkgo Bioworks Reports Third Quarter 2025 Financial Results (PR Newswire)
Nov-05-25 07:46AM	Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2025 Result (GuruFocus.com)
08:00AM	Loading…
Nov-03-25 08:00AM	Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium (PR Newswire)
Oct-31-25 08:00AM	Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture (PR Newswire) +8.16%
Oct-30-25 04:05PM	Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation (PR Newswire)
Oct-28-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts (Zacks)
Oct-23-25 08:00AM	Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program (PR Newswire)
Oct-22-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Oct-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know (Zacks) -12.37%
Oct-09-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks) -5.28% -11.29%
Oct-03-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know (Zacks) -7.87%
Sep-30-25 12:39PM	Ginkgo Bioworks Holdings Stock Scores RS Rating Upgrade (Investor's Business Daily) +10.20%
Sep-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Advances While Market Declines: Some Information for Investors (Zacks) -6.64%
Sep-04-25 08:00AM	Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium (Business Wire)
Aug-29-25 04:05PM	Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions (PR Newswire) -13.02%
Aug-20-25 08:01AM	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry (PR Newswire)
Aug-13-25 09:30AM	Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average (Zacks) +14.71%
Aug-12-25 08:01AM	Ginkgo Automation Appoints Brian?O'Sullivan as Head of Commercial to Accelerate External Growth (PR Newswire)
Aug-08-25 03:46AM	Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... (GuruFocus.com) -8.69%
Aug-07-25 05:01PM	Ginkgo Bioworks Reports Second Quarter 2025 Financial Results (PR Newswire)
Jul-31-25 09:30AM	Ginkgo Bioworks awarded $4.66M contract by PNNL (TipRanks)
08:01AM	Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation (PR Newswire)
Jul-30-25 09:01AM	Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy (PR Newswire)
Jul-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -6.31%
Jul-17-25 09:01AM	Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors (PR Newswire)
Jul-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know (Zacks)
Jul-10-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why (Zacks) -7.51%
Jul-01-25 06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-25-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know (Zacks)
May-21-25 04:05PM	Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer (PR Newswire) -7.38% -7.43%
May-08-25 11:36PM	Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.35%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 06:30PM	Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.79% +14.73%
05:00PM	Ginkgo Bioworks Reports First Quarter 2025 Financial Results (PR Newswire)
May-01-25 07:50AM	Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.56%
Apr-30-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
09:00AM	Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors (PR Newswire)
Apr-29-25 04:00PM	Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation (PR Newswire) -7.98%
Apr-23-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Apr-22-25 09:00AM	Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
09:00AM	Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation (PR Newswire)
Apr-16-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know (Zacks)
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha) +11.23%
Apr-10-25 09:55AM	Wall Street Analysts Think Ginkgo Bioworks (DNA) Could Surge 41.59%: Read This Before Placing a Bet (Zacks) +7.67%
09:00AM	Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain (PR Newswire)
Apr-01-25 10:26AM	Is Ginkgo Bioworks Holdings, Inc. (DNA) the Best Gene-Editing Stock to Buy? (Insider Monkey)
09:35AM	Here's Why Ginkgo Bioworks (DNA) is Poised for a Turnaround After Losing -28.84% in 4 Weeks (Zacks)
Mar-27-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) -7.13%
Mar-21-25 06:15PM	Ginkgo Bioworks Holdings, Inc. (DNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) +5.91%
Mar-14-25 09:35AM	After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) (Zacks) +7.89%
Mar-05-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why (Zacks)
Feb-25-25 05:00PM	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -11.47%
Feb-21-25 09:00AM	Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab (PR Newswire) -5.34%
Feb-20-25 08:01AM	Ginkgo Bioworks Partners with HaDEA in Up to 24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care (PR Newswire) -9.86%
Feb-18-25 08:00AM	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation (PR Newswire) -6.52%
Feb-06-25 08:01AM	Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series (PR Newswire) -16.38%
Jan-29-25 12:00PM	Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jan-23-25 08:01AM	Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) (PR Newswire)
Jan-13-25 08:01AM	Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors (PR Newswire) -9.41%
Jan-09-25 11:38AM	Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics (GlobeNewswire)
08:00AM	Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-17-24 12:00PM	All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy (Zacks)
08:11AM	Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program (PR Newswire)
Nov-12-24 05:01PM	Ginkgo Bioworks Reports Third Quarter 2024 Financial Results (PR Newswire)
08:01AM	Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing (PR Newswire)
Nov-05-24 07:00AM	Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation (PR Newswire)
Sep-24-24 07:01AM	NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture (PR Newswire)
Sep-18-24 07:01AM	Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology (PR Newswire) +8.81%
Sep-17-24 08:01AM	Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology (PR Newswire) +9.31%
Sep-04-24 04:30PM	Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement (PR Newswire)
Aug-30-24 07:00AM	Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) -5.64%
Aug-19-24 07:56AM	Upcoming Stock Splits This Week (August 19 to August 23) Stay Invested (TipRanks) +5.64%

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Canton Barry	10% Owner	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Shetty Reshma P.	See remarks	Apr 10 '26	Sale	6.43	124,727	802,494	436,422	Apr 13 05:00 PM
Coen Steven P.	Officer	Apr 13 '26	Proposed Sale	6.41	33,171	212,762		Apr 13 03:17 PM
Che Austin	Officer	Apr 13 '26	Proposed Sale	6.41	40,893	262,292		Apr 13 03:16 PM
Shetty Reshma P.	See remarks	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:02 PM
Shetty Reshma P.	See remarks	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:02 PM
Canton Barry	10% Owner	Apr 08 '26	Sale	6.93	13,155	91,164	351,684	Apr 10 05:01 PM
Canton Barry	10% Owner	Apr 09 '26	Sale	6.40	13,116	83,903	338,568	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 09 '26	Sale	6.40	109,767	702,179	316,483	Apr 10 05:01 PM
Kelly Jason R	See remarks	Apr 08 '26	Sale	6.93	97,015	672,314	426,250	Apr 10 05:01 PM
Shetty Reshma P.	Officer	Apr 10 '26	Proposed Sale	6.43	124,727	802,531		Apr 10 03:46 PM
Canton Barry	Officer	Apr 09 '26	Proposed Sale	6.40	13,116	83,906		Apr 09 04:20 PM
Kelly Jason R	Officer	Apr 09 '26	Proposed Sale	6.40	109,767	702,201		Apr 09 04:13 PM
Kelly Jason R	Officer	Apr 08 '26	Proposed Sale	6.93	97,015	672,343		Apr 08 04:14 PM
Canton Barry	Officer	Apr 08 '26	Proposed Sale	6.93	13,155	91,168		Apr 08 04:14 PM
Coen Steven P.	See remarks	Mar 16 '26	Sale	6.74	708	4,768	9,099	Mar 18 05:00 PM
Coen Steven P.	Officer	Mar 16 '26	Proposed Sale	6.74	708	4,769		Mar 16 04:13 PM
Che Austin	Officer	Mar 11 '26	Proposed Sale	6.31	2,200	13,882		Mar 11 10:14 AM
Che Austin	Officer	Feb 04 '26	Proposed Sale	8.80	2,200	19,360		Feb 04 09:52 AM
Coen Steven P.	See remarks	Jan 20 '26	Sale	8.92	972	8,667	8,321	Jan 22 04:12 PM
Coen Steven P.	Officer	Jan 20 '26	Proposed Sale	8.92	972	8,667		Jan 20 04:15 PM
Che Austin	Officer	Jan 07 '26	Proposed Sale	9.16	2,200	20,152		Jan 07 10:09 AM
Coen Steven P.	See remarks	Dec 15 '25	Sale	8.89	736	6,540	7,488	Dec 16 05:11 PM
Coen Steven P.	Officer	Dec 15 '25	Proposed Sale	8.89	736	6,540		Dec 15 04:20 PM
Che Austin	Officer	Dec 10 '25	Proposed Sale	9.54	2,200	20,988		Dec 10 11:09 AM
Che Austin	Officer	Nov 12 '25	Proposed Sale	8.50	2,200	18,700		Nov 12 10:06 AM
Coen Steven P.	See remarks	Oct 17 '25	Sale	13.65	1,312	17,907	6,738	Oct 21 04:56 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	15.00	5,609	84,135		Oct 21 02:53 PM
Coen Steven P.	Officer	Oct 21 '25	Proposed Sale	13.65	1,312	17,908		Oct 21 01:59 PM
Che Austin	Officer	Oct 08 '25	Proposed Sale	15.21	2,200	33,462		Oct 08 09:43 AM
Coen Steven P.	See remarks	Oct 01 '25	Sale	15.00	5,609	84,135	5,503	Oct 03 05:01 PM
HENRY CHRISTIAN O	Director	Sep 09 '25	Sale	11.06	10,000	110,600	24,310	Sep 10 04:06 PM
HENRY CHRISTIAN O	Director	Sep 08 '25	Sale	10.92	10,000	109,200	34,310	Sep 10 04:06 PM
Che Austin	Officer	Sep 10 '25	Proposed Sale	10.78	2,200	23,716		Sep 10 09:51 AM
HENRY CHRISTIAN O	Director	Sep 09 '25	Proposed Sale	11.06	10,000	110,600		Sep 09 11:06 AM
HENRY CHRISTIAN O	Director	Sep 08 '25	Proposed Sale	10.92	10,000	109,209		Sep 08 12:19 PM
Coen Steven P.	See remarks	Aug 22 '25	Sale	12.40	310	3,843	11,112	Aug 26 04:10 PM
Che Austin	Officer	Aug 06 '25	Proposed Sale	14.10	2,200	31,020		Aug 06 09:48 AM
Coen Steven P.	See remarks	Jul 17 '25	Sale	9.84	1,084	10,669	10,679	Jul 21 04:28 PM
Dmytruk Mark E.	Officer	Jul 17 '25	Proposed Sale	9.84	640	6,299		Jul 17 05:20 PM
Che Austin	Officer	Jul 09 '25	Proposed Sale	11.18	2,200	24,596		Jul 09 12:07 PM
Che Austin	Officer	Jun 23 '25	Proposed Sale	8.43	99	835		Jun 23 09:54 AM
Che Austin	Officer	Jun 20 '25	Proposed Sale	8.66	99	857		Jun 20 09:50 AM
Che Austin	Officer	Jun 18 '25	Proposed Sale	8.46	99	838		Jun 18 09:41 AM
Che Austin	Officer	Jun 17 '25	Proposed Sale	9.06	99	897		Jun 17 11:58 AM
Che Austin	Officer	Jun 16 '25	Proposed Sale	9.04	99	895		Jun 16 10:21 AM
Che Austin	Officer	Jun 13 '25	Proposed Sale	8.92	99	883		Jun 13 10:04 AM
Che Austin	Officer	Jun 12 '25	Proposed Sale	9.51	99	941		Jun 12 09:45 AM
Che Austin	Officer	Jun 11 '25	Proposed Sale	8.93	99	884		Jun 11 09:58 AM
Che Austin	Officer	Jun 10 '25	Proposed Sale	7.99	99	791		Jun 10 10:07 AM
Che Austin	Officer	Jun 09 '25	Proposed Sale	7.75	99	767		Jun 09 10:01 AM
Che Austin	Officer	Jun 06 '25	Proposed Sale	7.32	99	725		Jun 06 10:05 AM
Che Austin	Officer	Jun 05 '25	Proposed Sale	7.60	99	752		Jun 05 10:20 AM
Che Austin	Officer	Jun 04 '25	Proposed Sale	7.55	99	747		Jun 04 10:26 AM
Che Austin	Officer	Jun 03 '25	Proposed Sale	7.27	99	720		Jun 03 10:08 AM
Che Austin	Officer	Jun 02 '25	Proposed Sale	6.97	99	690		Jun 02 09:47 AM
Che Austin	Officer	May 30 '25	Proposed Sale	7.12	99	705		May 30 09:40 AM
Che Austin	Officer	May 29 '25	Proposed Sale	7.62	99	754		May 29 09:37 AM
Che Austin	Officer	May 28 '25	Proposed Sale	6.96	99	689		May 28 09:36 AM
Che Austin	Officer	May 27 '25	Proposed Sale	7.20	99	713		May 27 11:00 AM
Che Austin	Officer	May 23 '25	Proposed Sale	6.75	99	668		May 23 09:55 AM
Coen Steven P.	See remarks	May 21 '25	Sale	7.58	346	2,624	9,216	May 22 04:06 PM
Dmytruk Mark E.	See remarks	May 21 '25	Sale	7.58	706	5,355	46,226	May 22 04:05 PM
Che Austin	Officer	May 22 '25	Proposed Sale	7.15	99	708		May 22 09:54 AM
Dmytruk Mark E.	Officer	May 21 '25	Proposed Sale	7.58	706	5,355		May 21 04:11 PM
Che Austin	Officer	May 21 '25	Proposed Sale	7.86	99	778		May 21 09:54 AM
Che Austin	Officer	May 20 '25	Proposed Sale	8.10	99	802		May 20 09:41 AM
Che Austin	Officer	May 19 '25	Proposed Sale	7.70	99	762		May 19 11:03 AM
Che Austin	Officer	May 16 '25	Proposed Sale	7.72	99	764		May 16 09:40 AM
Che Austin	Officer	May 15 '25	Proposed Sale	7.73	99	765		May 15 10:57 AM
Che Austin	Officer	May 14 '25	Proposed Sale	8.01	99	793		May 14 10:18 AM
Che Austin	Officer	May 13 '25	Proposed Sale	8.40	99	832		May 13 09:48 AM
Che Austin	Officer	May 12 '25	Proposed Sale	8.16	99	808		May 12 09:44 AM
Che Austin	Officer	May 09 '25	Proposed Sale	7.97	99	789		May 09 09:40 AM
Che Austin	Officer	May 08 '25	Proposed Sale	7.49	99	742		May 08 09:46 AM
Che Austin	Officer	May 07 '25	Proposed Sale	6.83	99	676		May 07 09:52 AM
Che Austin	Officer	May 06 '25	Proposed Sale	6.75	99	668		May 06 09:41 AM
Che Austin	Officer	May 05 '25	Proposed Sale	7.00	99	693		May 05 09:58 AM
Che Austin	Officer	May 02 '25	Proposed Sale	7.15	99	708		May 02 09:41 AM
Che Austin	Officer	May 01 '25	Proposed Sale	7.47	99	740		May 01 10:07 AM
Che Austin	Officer	Apr 30 '25	Proposed Sale	7.14	99	707		Apr 30 09:59 AM
Che Austin	Officer	Apr 29 '25	Proposed Sale	7.94	99	786		Apr 29 09:51 AM
Che Austin	Officer	Apr 28 '25	Proposed Sale	7.95	99	787		Apr 28 09:50 AM
Che Austin	Officer	Apr 25 '25	Proposed Sale	7.92	99	784		Apr 25 09:49 AM
Che Austin	Officer	Apr 24 '25	Proposed Sale	7.68	99	760		Apr 24 09:47 AM
Coen Steven P.	See remarks	Apr 21 '25	Sale	7.28	997	7,261	8,819	Apr 23 05:03 PM
Dmytruk Mark E.	See remarks	Apr 21 '25	Sale	7.28	1,244	9,060	45,453	Apr 23 05:00 PM
Che Austin	Officer	Apr 23 '25	Proposed Sale	8.05	99	797		Apr 23 09:54 AM
Che Austin	Officer	Apr 22 '25	Proposed Sale	7.49	99	742		Apr 22 09:48 AM
Dmytruk Mark E.	Officer	Apr 21 '25	Proposed Sale	7.28	1,244	9,060		Apr 21 04:16 PM
Che Austin	Officer	Apr 21 '25	Proposed Sale	7.50	99	742		Apr 21 09:51 AM
Che Austin	Officer	Apr 17 '25	Proposed Sale	8.09	99	801		Apr 17 09:49 AM
Che Austin	Officer	Apr 16 '25	Proposed Sale	8.17	99	809		Apr 16 09:49 AM
Che Austin	Officer	Apr 15 '25	Proposed Sale	8.41	99	833		Apr 15 09:47 AM

PACB

Pacific Biosciences of California Inc

DNA

Ginkgo Bioworks Holdings Inc

Upgrade your Finviz experience